Shepherd Kaplan Krochuk’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-19,786
Closed -$1.98M 485
2015
Q1
$1.98M Sell
19,786
-8,363
-30% -$557K 0.35% 47
2014
Q4
$1.48M Hold
28,149
0.24% 86
2014
Q3
$723K Buy
28,149
+2,780
+11% +$59.1K 0.09% 167
2014
Q2
$565K Sell
25,369
-4,312
-15% -$94.3K 0.06% 203
2014
Q1
$913K Buy
+29,681
New +$798K 0.11% 154

Shepherd Kaplan Krochuk's ASPX Position: Q2 2015 in Review

Shepherd Kaplan Krochuk sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 19,786 shares — an estimated $1.98M sold.

Shepherd Kaplan Krochuk first reported a position in ASPX in Q1 2014 and held it in 5 quarters. The position peaked at $1.98M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Shepherd Kaplan Krochuk reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 19,786 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.98M.
  • Shepherd Kaplan Krochuk first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 5 quarters.
  • Shepherd Kaplan Krochuk's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.98M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2015, filed 14 Aug 2015.